TY - JOUR T1 -胸部肿瘤学的多学科问题:团队经验JF -欧洲呼吸杂志》乔和J SP - 626 LP - 627欧元——10.1183/13993003.00936 -2016六世- 48 - 3盟Sculier jean - paul Y1 - 2016/09/01 UR - //www.qdcxjkg.com/content/48/3/626.abstract N2 -在欧洲呼吸学会胸部肿瘤(ERS)计划[1],2014年《欧洲呼吸杂志》(收获)发起的一系列评论称为“胸肿瘤挑战和争议”[2]。188bet官网地址讨论了下列问题。每个胸椎分期和治疗方式的具体贡献并不总是明确确定的:哪些灰色区域仍然存在?关于肺癌的筛检计划，现在是否可以进行大规模的胸部电脑断层扫描?胸部肿瘤学中的多学科团队管理不仅仅是一个概念吗?考虑到个体化治疗时代肺癌管理的肿瘤组织取样，什么对分子检测足够?小型肺癌应采用哪种治疗方法:肺叶切除术、肺叶亚切除术还是立体定向照射?恶性胸膜间皮瘤综合治疗的位置在哪里?在没有有效结论的情况下，非劣效性试验如何影响胸部肿瘤学的实践? How should advanced nonsmall cell lung cancer (NSCLC) be treated: by targeted therapy, personalised chemotherapy or standard chemotherapy? What is the exact role of palliative care in the patient's management? What should be the approach to the staging of lung cancer, with regard to noninvasive, minimally invasive and invasive techniques? Which examinations (and at what time) should take place during the follow-up of the patient after lung cancer resection? What is the best management option for a patient with NSCLC, with an epidermal growth factor receptor activating mutation or with an Alk translocation?Introducing a new ERJ series examining the multidisciplinary character of thoracic oncology http://ow.ly/59bY300wrRS ER -